iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionBlue Fin Capital, Inc.
Latest Disclosed Ownership9,989 shares
Latest Disclosed Value $ 1,686,643
Blue Fin Capital, Inc. reports 0.96% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 28, 2026 - Blue Fin Capital, Inc. filed a 13F-HR form disclosing ownership of 9,989 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $1,686,643 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 9,894 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.96% during the quarter. The current value of the position is $1,309,058 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-28 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,989 95 0.96 1,687 1.02 0.2767
2026-01-23 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,894 0 0.00 1,670 16.88 0.2589
2025-11-21 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 9,894 -162 -1.61 1,428 12.26 0.2246
2025-08-13 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,056 -104 -1.02 1,272 -2.08 0.2166
2025-11-21 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,160 -159 -1.54 1,299 -4.77 0.2521
2025-02-18 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,319 -160 -1.53 1,364 -10.56 0.2514
2024-11-05 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,479 -37 -0.35 1,526 5.68 0.2899
2024-07-31 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,516 74 0.71 1,443 0.77 0.2882
2024-05-14 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,442 -301 -2.80 1,433 -1.85 0.3194
2024-02-06 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,743 -544 -4.82 1,459 5.72 0.3746
2023-10-19 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 11,287 -554 -4.68 1,380 -8.18 0.4031
2023-07-31 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 11,841 260 2.25 1,503 -0.40 0.4293
2023-05-12 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,581 288 2.55 1,509 1.82 0.4876
2023-01-23 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,293 -275 -2.38 1,483 9.62 0.5431
2022-11-04 2022-09-30 13F ISHARES BIOTECHNOLOGY ETF ISHARES BIOTECH 464287556 11,568 -492 -4.08 1,352 -4.65 0.5108
2022-08-08 2022-06-30 13F ISHARES BIOTECHNOLOGY FUND ISHARES BIOTECH 464287556 12,060 589 5.13 1,418 -5.09 0.5021
2022-04-12 2022-03-31 13F ISHARES BIOTECHNOLOGY FUND NASDAQ BIOTECH 464287556 11,471 -4,566 -28.47 1,494 -38.95 0.4330
2022-01-19 2021-12-31 13F ISHARES BIOTECHNOLOGY FUND ISHARES BIOTECH 464287556 16,037 3,721 30.21 2,447 22.90 0.6777
2021-10-25 2021-09-30 13F ISHARES BIOTECHNOLOGY FUND ISHARES BIOTECH 464287556 12,316 1,504 13.91 1,991 12.55 0.6078
2021-07-19 2021-06-30 13F ISHARES BIOTECHNOLOGY FUND ISHARES BIOTECH 464287556 10,812 112 1.05 1,769 9.88 0.5450
2021-05-05 2021-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 10,700 720 7.21 1,610 6.55 0.5518
2021-01-28 2020-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 9,980 1,030 11.51 1,511 24.77 0.5407
2020-10-28 2020-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 8,950 -580 -6.09 1,211 -6.99 0.4899
2020-08-10 2020-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 9,530 3,222 51.08 1,302 91.75 0.5763
2020-04-28 2020-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 6,308 154 2.50 679 -7.87 0.3748
2020-02-10 2019-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 6,154 806 15.07 737 38.53 0.3473
2019-11-07 2019-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 5,348 -400 -6.96 532 -15.15 0.2785
2019-07-22 2019-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 5,748 351 6.50 627 3.98 0.3231
2019-04-23 2019-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 5,397 1,967 57.35 603 82.73 0.3166
2019-01-16 2018-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 3,430 -1,566 -31.35 330 -45.81 0.1971
2018-12-27 2018-09-30 13F/A-2 ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 4,996 4,996 609 0.3016
2018-11-09 2018-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND NASDAQ BIOTECH 464287556 4,996 609
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.